About The Taskforce
The NYC LARC Access Taskforce aims to ensure that everyone has access to a full range of contraceptive methods, including highly effective long-acting reversible contraceptives (LARCs).
LARCs are highly effective and safe contraception options that can be removed when no longer desired. The Taskforce seeks to address the systemic barriers (financial, institutional, legal, and educational) that may limit knowledge, awareness, access, and use of LARCs, specifically IUDs and implants.
The Taskforce launched in January 2013 in response to a need expressed by the family planning provider community in New York City to share information, resources, and strategy. It is the first municipal-level taskforce working to facilitate city-wide, multidisciplinary coordination around IUD access. The LARC Taskforce’s newest project is the online LARC Community of Practice. A community of practice is a group of professionals that shares information, resources, and lessons learned about a specific topic.
LARC Taskforce Goals
The LARC Taskforce aims to create an environment that ensures that everyone has access to a full-range of contraceptive options, including the highly effective methods (IUDs and implants). The Taskforce aims to improve institutional and community readiness* by understanding and challenging obstacles to LARC usage at the individual (patient/healthcare provider), institutional, community, and policy levels.
*Community readiness refers to the degree a community and its institutions are prepared to take action on an issue. Learn more about Community Readiness here.
Taskforce Membership and Structure
[i] Trussell, J. “Contraceptive Failure in the United States.” Contraception 83 (2011): 397-404. Access from: http://www.kupferkette.info/downloads/contraceptive-failure-in-the-united-states---2.pdf
[ii] Grimes, D. “Forgettable Contraception.” Contraception. 80, 6(2009): 497-499. Accessed from: http://www.ncbi.nlm.nih.gov/pubmed/19913141
[iii] ACOG. " ACOG. "Adolescents & Long-Acting Reversible Contraception: Implants and Intrauterine Devices." Committee Opinion No. 405 (2009):. 1-5.5. Accessed from:http://www.acog.org/~/media/Committee%20Opinions/Committee%20on%20Gynecologic%20Practice/co450.pdf?dmc=1&ts=20140303T1553209882